Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Hiển thị phiên bản (1) khác

BACKGROUND: Immunomodulatory drugs have been shown to be only modestly effective in clinically definite relapsing remitting multiple sclerosis (RRMS). It has been hypothesized that their efficacy could be higher if used at the first appearance of symptoms, that is in the clinically isolated syndrom...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Clerico, M, Faggiano, F, Palace, J, Rice, G, Tintorè, M, Durelli, L
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2008

Những quyển sách tương tự

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
Bằng: Clerico, M, et al.
Được phát hành: (2008)

Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
Bằng: Clerico, M, et al.
Được phát hành: (2005)

Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
Bằng: Clerico, M, et al.
Được phát hành: (2006)

Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
Bằng: Clerico, M, et al.
Được phát hành: (2008)

Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials
Bằng: Clerico, M, et al.
Được phát hành: (2007)

Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort
Bằng: Valéria Coelho Santa Rita Pereira, et al.
Được phát hành: (2012-10-01)

Immunomodulatory treatments for preventing conversion from clinically isolated syndromes to multiple sclerosis: a Cochrane review on their efficacy
Bằng: Clerico, M, et al.
Được phát hành: (2007)

Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis
Bằng: Clerico, M, et al.
Được phát hành: (2008)

Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation
Bằng: GJ Melendez-Torres, et al.
Được phát hành: (2017-09-01)

A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis
Bằng: E.J. Ramos González, et al.
Được phát hành: (2021-05-01)

CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Bằng: Andrew F Tyler, et al.
Được phát hành: (2013-01-01)

To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis
Bằng: Clerico, M, et al.
Được phát hành: (2009)

A Cochrane review on immunomodulatory treatments in clinically isolated syndromes at risk of converting to multiple sclerosis
Bằng: Clerico, M, et al.
Được phát hành: (2006)

Manifestation of Susac syndrome during interferon beta-1a and glatiramer acetate treatment for misdiagnosed multiple sclerosis: a case report
Bằng: Joanna Roskal-Wałek, et al.
Được phát hành: (2021-09-01)

New features of glatiramer acetate for the treatment of remitting multiple sclerosis
Bằng: N. Y. Lasch
Được phát hành: (2015-12-01)

The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
Bằng: Katarzyna Kapica-Topczewska, et al.
Được phát hành: (2019-01-01)

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages
Bằng: G. J. Melendez-Torres, et al.
Được phát hành: (2018-10-01)

Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis
Bằng: G. Ya. Shvarts
Được phát hành: (2005-06-01)

Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
Bằng: Özlem Taşkapılıoğlu, et al.
Được phát hành: (2012-03-01)

Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
Bằng: Özlem Taşkapılıoğlu, et al.
Được phát hành: (2012-03-01)

Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Bằng: Oscar Fernández
Được phát hành: (2012-08-01)

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?
Bằng: Massimiliano Mirabella, et al.
Được phát hành: (2022-04-01)

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
Bằng: Mikhail Melnikov, et al.
Được phát hành: (2020-01-01)

Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Bằng: Oscar Fernández
Được phát hành: (2012-04-01)

Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.
Bằng: Niklas Bergvall, et al.
Được phát hành: (2014-01-01)

Nicolau syndrome following glatiramer acetate for multiple sclerosis: Case and review of reports
Bằng: Methma Udawatta, et al.
Được phát hành: (2024-04-01)

Drug-Induced Liver Injury by Glatiramer Acetate Used for Treatment of Multiple Sclerosis
Bằng: Attila Onmez, et al.
Được phát hành: (2013-12-01)

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
Bằng: Aaron Boster, et al.
Được phát hành: (2011-09-01)

A case of Disseminated Herpes Zoster in a patient with Multiple Sclerosis on Glatiramer acetate
Bằng: C. Halasan, et al.
Được phát hành: (2020-01-01)

Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple sclerosis
Bằng: P Tappenden, et al.
Được phát hành: (2004-06-01)

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
Bằng: Caporro M, et al.
Được phát hành: (2014-08-01)

Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Bằng: Anna Gil-Sánchez, et al.
Được phát hành: (2024-04-01)

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Bằng: Anne Waschbisch, et al.
Được phát hành: (2011-01-01)

Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis
Bằng: Genaro Gabriel Ortíz, et al.
Được phát hành: (2022-06-01)

Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
Bằng: Arielle Kasindi, et al.
Được phát hành: (2022-05-01)

Physicochemical and Biological Examination of Two Glatiramer Acetate Products
Bằng: Arthur Komlosh, et al.
Được phát hành: (2019-07-01)

Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate
Bằng: Ioana S. Barac, et al.
Được phát hành: (2023-06-01)

GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
Bằng: T. E. Shmidt
Được phát hành: (2016-12-01)

MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate
Bằng: Ignacio Casanova, et al.
Được phát hành: (2023-10-01)

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate
Bằng: Justin M. Honce, et al.
Được phát hành: (2020-09-01)